Literature DB >> 18289919

Clostridium difficile toxins: more than mere inhibitors of Rho proteins.

Harald Genth1, Stefanie C Dreger, Johannes Huelsenbeck, Ingo Just.   

Abstract

Toxin A (TcdA) and Toxin B (TcdB) are the major pathogenicity factors of the Clostridium difficile-associated diarrhoea (CDAD). The single-chained protein toxins enter their target cells by receptor-mediated endocytosis. New data show the critical role of auto-catalytic processing for target cell entry. Inside the cell, the toxins mono-glucosylate and thereby inactivate low molecular mass GTP-binding proteins of the Rho subfamily. Toxin-treated cells respond to RhoA glucosylation with up-regulation and activation of the pro-apoptotic Rho family protein RhoB. These data reinforce the critical role of the glucosyltransferase activity for programmed cell death and show that TcdA and TcdB, generally classified as broad-spectrum inhibitors of Rho proteins, are also capable of activating Rho proteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18289919     DOI: 10.1016/j.biocel.2007.12.014

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  51 in total

1.  Structural determinants of Clostridium difficile toxin A glucosyltransferase activity.

Authors:  Rory N Pruitt; Nicole M Chumbler; Stacey A Rutherford; Melissa A Farrow; David B Friedman; Ben Spiller; D Borden Lacy
Journal:  J Biol Chem       Date:  2012-01-20       Impact factor: 5.157

2.  Autoproteolytic cleavage mediates cytotoxicity of Clostridium difficile toxin A.

Authors:  Isa Kreimeyer; Friederike Euler; Alexander Marckscheffel; Helma Tatge; Andreas Pich; Alexandra Olling; Janett Schwarz; Ingo Just; Ralf Gerhard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-11-03       Impact factor: 3.000

3.  Rational design of small molecule inhibitors targeting RhoA subfamily Rho GTPases.

Authors:  Xun Shang; Fillipo Marchioni; Nisha Sipes; Chris R Evelyn; Moran Jerabek-Willemsen; Stefan Duhr; William Seibel; Matthew Wortman; Yi Zheng
Journal:  Chem Biol       Date:  2012-06-22

4.  Complement regulator Factor H mediates a two-step uptake of Streptococcus pneumoniae by human cells.

Authors:  Vaibhav Agarwal; Tauseef M Asmat; Shanshan Luo; Inga Jensch; Peter F Zipfel; Sven Hammerschmidt
Journal:  J Biol Chem       Date:  2010-05-26       Impact factor: 5.157

5.  Rational design of inhibitors and activity-based probes targeting Clostridium difficile virulence factor TcdB.

Authors:  Aaron W Puri; Patrick J Lupardus; Edgar Deu; Victoria E Albrow; K Christopher Garcia; Matthew Bogyo; Aimee Shen
Journal:  Chem Biol       Date:  2010-11-24

Review 6.  Recurrent Clostridium difficile infection: From colonization to cure.

Authors:  Kelsey Shields; Roger V Araujo-Castillo; Thimmaiah G Theethira; Carolyn D Alonso; Ciaran P Kelly
Journal:  Anaerobe       Date:  2015-04-27       Impact factor: 3.331

7.  Current Status of Nonantibiotic and Adjunct Therapies for Clostridium difficile Infection.

Authors:  Nuntra Suwantarat; David A Bobak
Journal:  Curr Infect Dis Rep       Date:  2011-02       Impact factor: 3.725

Review 8.  Taming the Beast: Interplay between Gut Small Molecules and Enteric Pathogens.

Authors:  Aman Kumar; Melissa Ellermann; Vanessa Sperandio
Journal:  Infect Immun       Date:  2019-08-21       Impact factor: 3.441

9.  Nonantimicrobial drug targets for Clostridium difficile infections.

Authors:  Charles Darkoh; Magdalena Deaton; Herbert L DuPont
Journal:  Future Microbiol       Date:  2017-07-31       Impact factor: 3.165

10.  Actin re-organization induced by Chlamydia trachomatis serovar D--evidence for a critical role of the effector protein CT166 targeting Rac.

Authors:  Jessica Thalmann; Katrin Janik; Martin May; Kirsten Sommer; Jenny Ebeling; Fred Hofmann; Harald Genth; Andreas Klos
Journal:  PLoS One       Date:  2010-03-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.